FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4210730536> ?p ?o ?g. }

• W4210730536 endingPage "i303" @default.
• W4210730536 startingPage "i302" @default.
• W4210730536 abstract "Abstract Background Bowel urgency, the sudden and immediate need to have a bowel movement, is a common symptom in ulcerative colitis (UC) and is associated with higher disease activity, decreased work productivity and markedly reduced quality of life1. This study explored differences in disease burden among UC patients with bowel urgency based on their treatment pathway. Methods Data were extracted from the Adelphi Disease Specific Programme for UC, a point-in-time survey of gastroenterologists (GIs) and patients from Jan 2020-Mar 2021 in Germany, France, Spain, Italy, UK and US. GIs provided patient demographics, clinical characteristics and treatment history. The same patients were invited to complete the Short Inflammatory Bowel Disease Questionnaire (SIBDQ), EQ-5D and Work Productivity and Activity Impairment (WPAI) questionnaire. Three patient subgroups were identified: never received targeted therapy (biologics and JAK inhibitors) (TT-naïve), receiving first TT currently (1L TT) and receiving TT with prior TT use (TT-exp). Within these groups, patients currently experiencing day- or nighttime bowel urgency, reported by physicians, with current treatment duration &gt;3 months, were included. ANOVA, chi-squared and Kruskal-Wallis tests were used to compare the groups. Results Of the UC patients in the TT-naïve (n=595), 1L TT (n=851) and TT-exp (n=321) groups, 23%, 17% and 26% experienced bowel urgency, respectively. Of those with bowel urgency, TT-naïve patients were younger with lower BMI and the lowest proportion of never smokers vs. the 1L TT and TT-exp groups (Table 1). 70–80% of patients across the three groups remained in non-remission based on the derived Mayo score, while 19% of the TT-naïve group were flaring vs. 18% 1L TT and 32% TT-exp patients (p=0.0324). Steroid use was highest in the TT-naïve group (43%) vs. 10% 1L TT and 17% TT-exp (p&lt;0.0001). 1L TT had the highest number of visits to healthcare professionals in the last 12 months. The patient reported outcome measures indicated substantial and similar quality of life impairment across all patients with bowel urgency (Table 2). The only significant difference was across impairment while working (31% TT-naïve, 17% 1L TT, 28% TT-exp; p=0.0232). Conclusion This study confirmed that a substantial proportion of patients across all three groups still experience bowel urgency despite receiving treatment. Since bowel urgency is known to negatively impact patients’ quality of life, there is a therapeutic need to address this symptom. Reference 1. Ha, C, et al. Rectal Urgency Among Ulcerative Colitis and Crohn’s Disease Patients: Analyses from a Global Survey. Poster presented at: Digestive Disease Week; 2021 May 21–23; Online event." @default.
• W4210730536 created "2022-02-08" @default.
• W4210730536 creator A5006524407 @default.
• W4210730536 creator A5012420519 @default.
• W4210730536 creator A5013088138 @default.
• W4210730536 creator A5034003178 @default.
• W4210730536 creator A5036000544 @default.
• W4210730536 creator A5051475694 @default.
• W4210730536 creator A5063199784 @default.
• W4210730536 creator A5076906147 @default.
• W4210730536 creator A5077691071 @default.
• W4210730536 date "2022-01-01" @default.
• W4210730536 modified "2023-09-26" @default.
• W4210730536 title "P261 Burden of bowel urgency across specific treatment groups among Ulcerative Colitis patients – real world global study analyses" @default.
• W4210730536 doi "https://doi.org/10.1093/ecco-jcc/jjab232.388" @default.
• W4210730536 hasPublicationYear "2022" @default.
• W4210730536 type Work @default.
• W4210730536 citedByCount "1" @default.
• W4210730536 countsByYear W42107305362023 @default.
• W4210730536 crossrefType "journal-article" @default.
• W4210730536 hasAuthorship W4210730536A5006524407 @default.
• W4210730536 hasAuthorship W4210730536A5012420519 @default.
• W4210730536 hasAuthorship W4210730536A5013088138 @default.
• W4210730536 hasAuthorship W4210730536A5034003178 @default.
• W4210730536 hasAuthorship W4210730536A5036000544 @default.
• W4210730536 hasAuthorship W4210730536A5051475694 @default.
• W4210730536 hasAuthorship W4210730536A5063199784 @default.
• W4210730536 hasAuthorship W4210730536A5076906147 @default.
• W4210730536 hasAuthorship W4210730536A5077691071 @default.
• W4210730536 hasBestOaLocation W42107305361 @default.
• W4210730536 hasConcept C126322002 @default.
• W4210730536 hasConcept C139719470 @default.
• W4210730536 hasConcept C144024400 @default.
• W4210730536 hasConcept C149923435 @default.
• W4210730536 hasConcept C159110408 @default.
• W4210730536 hasConcept C162324750 @default.
• W4210730536 hasConcept C204983608 @default.
• W4210730536 hasConcept C2778260677 @default.
• W4210730536 hasConcept C2779134260 @default.
• W4210730536 hasConcept C2779951463 @default.
• W4210730536 hasConcept C2780084366 @default.
• W4210730536 hasConcept C2780479503 @default.
• W4210730536 hasConcept C2992962319 @default.
• W4210730536 hasConcept C71924100 @default.
• W4210730536 hasConcept C90924648 @default.
• W4210730536 hasConceptScore W4210730536C126322002 @default.
• W4210730536 hasConceptScore W4210730536C139719470 @default.
• W4210730536 hasConceptScore W4210730536C144024400 @default.
• W4210730536 hasConceptScore W4210730536C149923435 @default.
• W4210730536 hasConceptScore W4210730536C159110408 @default.
• W4210730536 hasConceptScore W4210730536C162324750 @default.
• W4210730536 hasConceptScore W4210730536C204983608 @default.
• W4210730536 hasConceptScore W4210730536C2778260677 @default.
• W4210730536 hasConceptScore W4210730536C2779134260 @default.
• W4210730536 hasConceptScore W4210730536C2779951463 @default.
• W4210730536 hasConceptScore W4210730536C2780084366 @default.
• W4210730536 hasConceptScore W4210730536C2780479503 @default.
• W4210730536 hasConceptScore W4210730536C2992962319 @default.
• W4210730536 hasConceptScore W4210730536C71924100 @default.
• W4210730536 hasConceptScore W4210730536C90924648 @default.
• W4210730536 hasIssue "Supplement_1" @default.
• W4210730536 hasLocation W42107305361 @default.
• W4210730536 hasOpenAccess W4210730536 @default.
• W4210730536 hasPrimaryLocation W42107305361 @default.
• W4210730536 hasRelatedWork W2044341494 @default.
• W4210730536 hasRelatedWork W2070285775 @default.
• W4210730536 hasRelatedWork W2124908533 @default.
• W4210730536 hasRelatedWork W2258300052 @default.
• W4210730536 hasRelatedWork W2408939568 @default.
• W4210730536 hasRelatedWork W2409879998 @default.
• W4210730536 hasRelatedWork W2412773332 @default.
• W4210730536 hasRelatedWork W2418837291 @default.
• W4210730536 hasRelatedWork W2512626908 @default.
• W4210730536 hasRelatedWork W46359855 @default.
• W4210730536 hasVolume "16" @default.
• W4210730536 isParatext "false" @default.
• W4210730536 isRetracted "false" @default.
• W4210730536 workType "article" @default.